Genetic Risk Marker Found for Depression
the Psychiatry Advisor take:
A genetic variant known to be connected to an increased risk for developing Alzheimer’s disease may also be associated with an elevated risk of late-life depression.
Silke Kern, PhD, of the University of Gothenburg, Sweden, and colleagues looked at the relationship between the epsilon 4 (ε4) allele of the apolipoprotein gene (APOE) and depression in 839 older Swedish adults who were followed for more than five years.
The APOE ε4 allele correctly predicted future depression, even after excluding people who later developed dementia, the researchers reported in the journal Biological Psychiatry. Among subjects without depression at study entry and without dementia or significant cognitive decline during the subsequent nine years, APOE ε4 was prospectively associated with more severe depressive symptoms, incident minor depression, and any depression.
“APOE ε4 might be a marker for identifying older persons at risk to develop depression or dementia, which could be important for prevention and early detection of these common disorders,” Kern said in a statement.
APOE ε4 has also been associated with atherosclerosis as well as cardiovascular and cerebrovascular disease.
The APOE ε4 allele correctly predicted future depression, even after excluding people who later developed dementia.
One of the most powerful predictors in neuropsychiatry is the epsilon 4 (ε4) allele of the apolipoprotein gene (APOE).
Individuals who carry this ε4 variant of APOE are at increased risk for developing Alzheimer's disease, early age of Alzheimer's disease onset, and more rapid progression of Alzheimer's disease symptoms. APOE ε4 has also been associated with atherosclerosis as well as cardiovascular and cerebrovascular disease.
A new study published in the current issue of Biological Psychiatry suggests that even when controlling for the risk for Alzheimer's disease, the APOE ε4 allele also conveys an increased risk for late-life depression.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Addressing Depression in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome
- Childhood-Onset Bipolar Disorder Associated With Impaired Family Functioning
- Valproate Use in Women Who Could Become Pregnant: The Argument for Informed Consent
- Review Examines the Effectiveness of Antidepressants for Insomnia
- Ketamine-Induced Dissociative Symptoms Predict Antidepressant Response
- Video Games and Exercise as Alternative Therapies for ADHD
- How Parents Can Enhance Autism Treatment: Use of Intervention Strategies at Home
- Electroconvulsive Therapy Effective in Children With Autism
- Comorbid Autism Spectrum Disorder and OCD: Challenges in Diagnosis and Treatment
- The Cutting Edge of Schizophrenia Research: VR as Treatment for Psychosis
- New APA President Takes Office as the First African-American to Lead the Organization
- "MDMA-Assisted Psychotherapy Effective for Treating PTSD in Veterans, First Responders "
- Early Intervention Services Superior to Treatment as Usual for Early-Phase Psychosis
- Depressive Symptoms Predict Future Pain, Disability in Adolescent JIA
- Gender-Related Association Between Physical Activity, Psychological Status in T2D